Amjad Mohammad Asim, Ocazionez Trujillo Daniel, Estrada-Y-Martin Rosa M, Cherian Sujith V
Divisions of Critical Care, Pulmonary and Sleep Medicine, Department of Internal Medicine, University of Texas Health-McGovern Medical School, 6431 Fannin Street, MSB 1.434, Houston, TX 77030, USA.
Department of Diagnostic and Interventional Imaging, University of Texas Health-McGovern Medical School, Houston, TX 77030, USA.
Int J Environ Res Public Health. 2025 May 17;22(5):792. doi: 10.3390/ijerph22050792.
E-cigarette or vaping product use-associated lung injury (EVALI) is a critical and potentially fatal form of lung injury that gained considerable public health concern in 2019. The use of e-cigarettes and vaping products is causally associated with EVALI, a condition characterized by a constellation of respiratory symptoms, such as coughing, shortness of breath, and chest pain. This comprehensive narrative literature review explores the complexities of EVALI, including its association with the structure and composition of e-cigarettes and its epidemiology, pathogenesis, clinical and radiological manifestations, management strategies, and public health implications. Moreover, it uncovers the long-term repercussions of EVALI and underscores the ongoing research endeavors designed to mitigate and comprehend the risks associated with using e-cigarettes.
电子烟或雾化产品使用相关肺损伤（EVALI）是一种严重且可能致命的肺损伤形式，在2019年引起了相当大的公共卫生关注。电子烟和雾化产品的使用与EVALI存在因果关系，EVALI是一种以一系列呼吸道症状为特征的疾病，如咳嗽、呼吸急促和胸痛。这篇全面的叙述性文献综述探讨了EVALI的复杂性，包括其与电子烟的结构和成分的关联及其流行病学、发病机制、临床和放射学表现、管理策略以及公共卫生影响。此外，它还揭示了EVALI的长期影响，并强调了为减轻和理解与使用电子烟相关的风险而正在进行的研究工作。
